Common ssri
Pro Research Analysisby 
Searched over 200M research papers for "common ssri"
Common SSRIs: Efficacy, Safety, and Adverse Effects
Introduction to SSRIs
Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs commonly prescribed for mood and anxiety disorders. They function by increasing serotonin levels in the brain, which can help improve mood and reduce anxiety. This article synthesizes recent research on the efficacy, safety, and adverse effects of SSRIs across different populations and conditions.
Efficacy of SSRIs in Different Age Groups
Children and Adolescents
SSRIs are frequently prescribed to children and adolescents for depressive disorders, but their efficacy and safety in these age groups are subjects of ongoing research. Studies indicate that while SSRIs can be effective, they also come with a higher risk of adverse effects, including increased suicidal ideation and behavior4. Fluoxetine is the only SSRI consistently shown to reduce depression symptoms in both children and adolescents4.
Adults
In adults, SSRIs are generally effective for treating depressive and anxiety disorders. However, the response to treatment can vary based on individual genetic factors, such as polymorphisms in the serotonin transporter gene (SLC6A4)2. The S allele of the 5-HTTLPR polymorphism is associated with a higher burden of adverse drug reactions, particularly gastrointestinal issues and antidepressant-induced mania2.
Adverse Effects of SSRIs
Common Adverse Effects
The most common adverse effects of SSRIs include nausea, insomnia, and somnolence. These effects are generally consistent across different age groups, although their prevalence can vary. For instance, activation and vomiting are more common in children, while somnolence increases with age1. Insomnia and nausea are prevalent across all age groups1.
Serious Adverse Effects
Serious adverse effects, such as increased suicidal ideation and behavior, are particularly concerning in younger populations. Studies have shown that children and adolescents on SSRIs have a higher risk of these outcomes compared to those on placebo4. Additionally, prenatal exposure to SSRIs has been linked to an increased risk of autism spectrum disorder (ASD) in offspring3.
Safety in Overdose
SSRIs are generally considered safer in overdose compared to older antidepressants like tricyclic antidepressants (TCAs). Overdoses of SSRIs alone are rarely fatal and usually result in minor symptoms such as drowsiness, tremor, nausea, and vomiting. However, severe adverse events can occur at very high doses, and the risk increases significantly when SSRIs are taken in combination with other substances8.
SSRIs for Other Conditions
Migraine and Tension-Type Headaches
SSRIs have been evaluated for the prevention of migraine and tension-type headaches (TTH). However, the evidence does not support their efficacy for these conditions. SSRIs are no more effective than placebo for migraine prevention and are less effective than tricyclic antidepressants for TTH7 9 10.
Conclusion
SSRIs are a cornerstone in the treatment of mood and anxiety disorders, offering significant benefits but also posing risks, particularly in younger populations. Their efficacy and safety can be influenced by genetic factors, and they are generally safer in overdose compared to older antidepressants. However, their use for conditions like migraine and TTH is not well-supported by current evidence. As with any medication, the benefits and risks must be carefully weighed, particularly in vulnerable populations such as children and pregnant women.
Sources and full results
Most relevant research papers on this topic
Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents.
Children are more vulnerable to specific adverse events from SSRIs, likely due to their biological immaturity.
Meta-Analysis
Highly CitedSerotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence
The S allele of 5HTTLPR may predict increased adverse event burden during SSRI therapy, with the most convincing evidence in antidepressant-induced mania and gastrointestinal adverse events.
Systematic ReviewMaternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review
Prenatal exposure to SSRIs is associated with a higher risk of autism spectrum disorder in offspring.
Meta-Analysis
Rigorous JournalHighly CitedSelective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
SSRIs show potential in reducing depression symptoms in children and adolescents, but their effectiveness is limited by methodological issues and potential increased risk of suicidal outcomes.
Meta-AnalysisHighly CitedSerotonin transporter gene polymorphisms and SSRI tolerability: review of pharmacogenetic evidence
The S allele of 5-HTTLPR may predict increased adverse event burden during SSRI therapy, with the most convincing evidence in antidepressant-induced mania and gastrointestinal adverse events.
Systematic ReviewEfficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis
SSRIs and SNRIs are significantly more effective and safer than placebo for treating common psychiatric disorders in children and adolescents, with SSRIs showing a larger effect size for anxiety disorders.
Meta-AnalysisHighly CitedSelective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches.
SSRIs are no more effective than placebo in preventing migraine and tension-type headaches after 2 months of treatment.
Meta-AnalysisHighly CitedSSRI safety in overdose.
SSRI antidepressants are far safer than TCAs in overdose, with no apparent difference among them in overdose safety.
Systematic ReviewHighly CitedSelective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
SSRIs and SNRIs show limited efficacy and tolerability in preventing episodic and chronic migraine in adults, with limited evidence from small, inconclusive studies.
Systematic Review
Very Rigorous JournalSelective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
SSRIs and SNRIs show promising efficacy and tolerability in preventing tension-type headaches in adults compared to placebo and other active interventions.
Systematic ReviewVery Rigorous Journal